Cannabidiol, or CBD, is a compound found in the cannabis sativa plant that has been gaining attention in recent years due to its potential therapeutic benefits. In response to this growing interest, the World Health Organization (WHO) conducted a review of cannabis and cannabis-related substances, including CBD. This article will provide an overview of the WHO review and discuss the potential therapeutic benefits of CBD. The WHO review was based on a request from the Commission on Narcotic Drugs (CND). The purpose of the review was to synthesize the evidence available from clinical research regarding the effectiveness of CBD as a therapeutic agent.
Research on CBD and epilepsy is more advanced than the use of CBD to treat other medical conditions, but there is some evidence, both preclinical and clinical, that CBD could have “neuroprotective, antiepileptic, hypoxia-ischemia, anxiolytic, antipsychotic, analgesic, anti-inflammatory, anti-asthmatic, and antitumor properties.”For example, one study found that an orally administered dose of 600 mg of CBD did not differ from placebo on the Addiction Research Center Inventory scales, a 16-item analog visual mood scale, subjective level of intoxication, or psychotic symptoms. This suggests that CBD may have potential therapeutic benefits for a variety of medical conditions, from arthritis to depression. In addition to its potential therapeutic benefits, CBD has also been found to be safe. Unlike the release of dopamine into cells that occurs with most drugs of abuse, during animal testing, CBD showed no such release. This has led to a change in the way CBD is socially perceived and the market for CBD products is steadily growing. When selecting a CBD product it is important to ensure that safety standards are met.
Companies can do this by sending samples of their product to an independent, accredited laboratory for analysis. Made with organically grown hemp on the company's central Oregon farm, this THC-free CBD oil tincture contains high-quality, fractionally distilled, crystallized CBD isolate. It is available in several strengths ranging from 300 milligrams to 3000 milligrams of CBD per 30 milliliter bottle. To select the best CBD oils, the Forbes Health editorial team analyzed data from more than 100 CBD oil products made from plants grown in the USA. UU.
The team looked at factors such as potency, purity and quality control measures. They also considered customer reviews and ratings. In conclusion, there is evidence that suggests that CBD may have potential therapeutic benefits for a variety of medical conditions. It is important to ensure that safety standards are met when selecting a product by sending samples to an independent laboratory for analysis. With more research being conducted on the potential therapeutic benefits of CBD, it is likely that we will continue to learn more about this compound in the future.
Leave Reply